Congenital hypothyroidism with gland in situ

Diagnostic re-evaluation

G. Weber, M. C. Vigone, A. Passoni, M. Odoni, P. L. Paesano, F. Dosio, M. C. Proverbio, C. Corbetta, L. Persani, G. Chiumello

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In the past, most congenital hypothyroidism (CH) children with thyroid gland in situ were considered to be affected by hormonogenesis defect. Nowadays, the improved sensitivity of neonatal screening, novel insights into the pathogenic mechanisms and the advances of genetic analyses have reopened the discussion about the etiology of CH with thyroid in situ. We report the etiological re-evaluation of 31 children with thyroid in situ, who had been identified by the CH screening program. The purposes of this re-evaluation were: a) to investigate the definitive diagnosis and pathogenetic mechanism of CH with thyroid in situ in eligible children suspected of dyshormonogenetic defect and b) to verify the adequacy of the treatment schedules. Thirty out of 31 children were affected with permanent hypothyroidism and only one child was euthyroid at re-evaluation (transient CH). Thyroid hormone organisation defects were present in less than half of the CH patients with thyroid in situ (13/30); a higher prevalence of partial defects of iodine organification than severe or complete forms was found. An inactivating TSH-receptor gene mutation was found in only one patient without iodine organification defect. Some questions remain unanswered concerning the adequacy of the schedules of treatment, particularly about the proper treatment of mild and borderline forms of CH.

Original languageEnglish
Pages (from-to)516-522
Number of pages7
JournalJournal of Endocrinological Investigation
Volume28
Issue number6
Publication statusPublished - 2005

Fingerprint

Congenital Hypothyroidism
Thyroid Gland
Iodine
Appointments and Schedules
Neonatal Screening
Thyrotropin Receptors
Hypothyroidism
Thyroid Hormones
Therapeutics
Organizations
Mutation
Genes

Keywords

  • Congenital hypothyroidism
  • Dyshormonogenesis
  • Hyperthyrotropinemia
  • Iodide organification defect
  • Perchlorate discharge test

ASJC Scopus subject areas

  • Endocrinology

Cite this

Weber, G., Vigone, M. C., Passoni, A., Odoni, M., Paesano, P. L., Dosio, F., ... Chiumello, G. (2005). Congenital hypothyroidism with gland in situ: Diagnostic re-evaluation. Journal of Endocrinological Investigation, 28(6), 516-522.

Congenital hypothyroidism with gland in situ : Diagnostic re-evaluation. / Weber, G.; Vigone, M. C.; Passoni, A.; Odoni, M.; Paesano, P. L.; Dosio, F.; Proverbio, M. C.; Corbetta, C.; Persani, L.; Chiumello, G.

In: Journal of Endocrinological Investigation, Vol. 28, No. 6, 2005, p. 516-522.

Research output: Contribution to journalArticle

Weber, G, Vigone, MC, Passoni, A, Odoni, M, Paesano, PL, Dosio, F, Proverbio, MC, Corbetta, C, Persani, L & Chiumello, G 2005, 'Congenital hypothyroidism with gland in situ: Diagnostic re-evaluation', Journal of Endocrinological Investigation, vol. 28, no. 6, pp. 516-522.
Weber G, Vigone MC, Passoni A, Odoni M, Paesano PL, Dosio F et al. Congenital hypothyroidism with gland in situ: Diagnostic re-evaluation. Journal of Endocrinological Investigation. 2005;28(6):516-522.
Weber, G. ; Vigone, M. C. ; Passoni, A. ; Odoni, M. ; Paesano, P. L. ; Dosio, F. ; Proverbio, M. C. ; Corbetta, C. ; Persani, L. ; Chiumello, G. / Congenital hypothyroidism with gland in situ : Diagnostic re-evaluation. In: Journal of Endocrinological Investigation. 2005 ; Vol. 28, No. 6. pp. 516-522.
@article{024b4f2d00164e09bb22e8578d19aa7e,
title = "Congenital hypothyroidism with gland in situ: Diagnostic re-evaluation",
abstract = "In the past, most congenital hypothyroidism (CH) children with thyroid gland in situ were considered to be affected by hormonogenesis defect. Nowadays, the improved sensitivity of neonatal screening, novel insights into the pathogenic mechanisms and the advances of genetic analyses have reopened the discussion about the etiology of CH with thyroid in situ. We report the etiological re-evaluation of 31 children with thyroid in situ, who had been identified by the CH screening program. The purposes of this re-evaluation were: a) to investigate the definitive diagnosis and pathogenetic mechanism of CH with thyroid in situ in eligible children suspected of dyshormonogenetic defect and b) to verify the adequacy of the treatment schedules. Thirty out of 31 children were affected with permanent hypothyroidism and only one child was euthyroid at re-evaluation (transient CH). Thyroid hormone organisation defects were present in less than half of the CH patients with thyroid in situ (13/30); a higher prevalence of partial defects of iodine organification than severe or complete forms was found. An inactivating TSH-receptor gene mutation was found in only one patient without iodine organification defect. Some questions remain unanswered concerning the adequacy of the schedules of treatment, particularly about the proper treatment of mild and borderline forms of CH.",
keywords = "Congenital hypothyroidism, Dyshormonogenesis, Hyperthyrotropinemia, Iodide organification defect, Perchlorate discharge test",
author = "G. Weber and Vigone, {M. C.} and A. Passoni and M. Odoni and Paesano, {P. L.} and F. Dosio and Proverbio, {M. C.} and C. Corbetta and L. Persani and G. Chiumello",
year = "2005",
language = "English",
volume = "28",
pages = "516--522",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "6",

}

TY - JOUR

T1 - Congenital hypothyroidism with gland in situ

T2 - Diagnostic re-evaluation

AU - Weber, G.

AU - Vigone, M. C.

AU - Passoni, A.

AU - Odoni, M.

AU - Paesano, P. L.

AU - Dosio, F.

AU - Proverbio, M. C.

AU - Corbetta, C.

AU - Persani, L.

AU - Chiumello, G.

PY - 2005

Y1 - 2005

N2 - In the past, most congenital hypothyroidism (CH) children with thyroid gland in situ were considered to be affected by hormonogenesis defect. Nowadays, the improved sensitivity of neonatal screening, novel insights into the pathogenic mechanisms and the advances of genetic analyses have reopened the discussion about the etiology of CH with thyroid in situ. We report the etiological re-evaluation of 31 children with thyroid in situ, who had been identified by the CH screening program. The purposes of this re-evaluation were: a) to investigate the definitive diagnosis and pathogenetic mechanism of CH with thyroid in situ in eligible children suspected of dyshormonogenetic defect and b) to verify the adequacy of the treatment schedules. Thirty out of 31 children were affected with permanent hypothyroidism and only one child was euthyroid at re-evaluation (transient CH). Thyroid hormone organisation defects were present in less than half of the CH patients with thyroid in situ (13/30); a higher prevalence of partial defects of iodine organification than severe or complete forms was found. An inactivating TSH-receptor gene mutation was found in only one patient without iodine organification defect. Some questions remain unanswered concerning the adequacy of the schedules of treatment, particularly about the proper treatment of mild and borderline forms of CH.

AB - In the past, most congenital hypothyroidism (CH) children with thyroid gland in situ were considered to be affected by hormonogenesis defect. Nowadays, the improved sensitivity of neonatal screening, novel insights into the pathogenic mechanisms and the advances of genetic analyses have reopened the discussion about the etiology of CH with thyroid in situ. We report the etiological re-evaluation of 31 children with thyroid in situ, who had been identified by the CH screening program. The purposes of this re-evaluation were: a) to investigate the definitive diagnosis and pathogenetic mechanism of CH with thyroid in situ in eligible children suspected of dyshormonogenetic defect and b) to verify the adequacy of the treatment schedules. Thirty out of 31 children were affected with permanent hypothyroidism and only one child was euthyroid at re-evaluation (transient CH). Thyroid hormone organisation defects were present in less than half of the CH patients with thyroid in situ (13/30); a higher prevalence of partial defects of iodine organification than severe or complete forms was found. An inactivating TSH-receptor gene mutation was found in only one patient without iodine organification defect. Some questions remain unanswered concerning the adequacy of the schedules of treatment, particularly about the proper treatment of mild and borderline forms of CH.

KW - Congenital hypothyroidism

KW - Dyshormonogenesis

KW - Hyperthyrotropinemia

KW - Iodide organification defect

KW - Perchlorate discharge test

UR - http://www.scopus.com/inward/record.url?scp=25144480496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144480496&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 516

EP - 522

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 6

ER -